We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-29.17%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$127M
Cap. Flow
-$58.3M
Cap. Flow %
-47.69%
Top 10 Hldgs %
25.43%
Holding
188
New
64
Increased
19
Reduced
68
Closed
36

Top Buys

Rank Stock Value
1
RMR icon
The RMR Group
RMR
+$4.54M
2
IDCC icon
InterDigital
IDCC
+$4.48M
3
LRN icon
Stride
LRN
+$4.07M
4
MSTR icon
Strategy Inc
MSTR
+$2.79M
5
VVV icon
Valvoline
VVV
+$2.6M

Top Sells

Rank Stock Value
1
JBLU icon
JetBlue
JBLU
+$6.96M
2
SAVE
Spirit Airlines, Inc.
SAVE
+$5.53M
3
BHC icon
Bausch Health
BHC
+$4.16M
4
RJF icon
Raymond James Financial
RJF
+$4.11M
5
AIT icon
Applied Industrial Technologies
AIT
+$3.52M

Sector Composition

Rank Sector Weight
1 Technology 22.23%
2 Consumer Discretionary 15.57%
3 Industrials 12.32%
4 Healthcare 9.67%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIG
176
CALL
DELISTED
Big Lots, Inc.
BIG
– –
-636
Closed -$48K
SDC
177
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
– –
-127,396
Closed -$1.11M
ATTO
178
DELISTED
Atento S.A.
ATTO
– –
-71,638
Closed -$1.04M
CHNG
179
DELISTED
Change Healthcare Inc. Common Stock
CHNG
– –
-71,377
Closed -$1.17M
CNR
180
DELISTED
Cornerstone Building Brands, Inc.
CNR
– –
-217,395
Closed -$1.85M
TVTY
181
DELISTED
Tivity Health, Inc. Common Stock
TVTY
– –
-52,401
Closed -$1.07M
RDS.A
182
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
– –
-53,343
Closed -$3.15M
CVA
183
DELISTED
Covanta Holding Corporation
CVA
– –
-173,214
Closed -$2.57M
FRAN
184
DELISTED
Francesca's Holdings Corporation
FRAN
– –
-31,353
Closed -$326K
TECD
185
DELISTED
Tech Data Corp
TECD
– –
-119,657
Closed -$1.43M
LBY
186
DELISTED
Libbey, Inc.
LBY
– –
-18,143
Closed -$26K
AVX
187
DELISTED
AVX Corporation
AVX
– –
-3,166
Closed -$65K
CISN
188
DELISTED
Cision Ltd. Ordinary Share
CISN
– –
-8,485
Closed -$85K
4 5 6 7
8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Invenomic Capital Management held 188 positions worth $122M, down 51% from $249M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management withdrew a net $58.3M in Q1 2020, closing 36 positions and reducing 68 holdings. Its most notable exit was JetBlue, an estimated $6.96M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Invenomic Capital Management opened a new position in The RMR Group worth $3.16M.

  • Invenomic Capital Management's largest Q1 2020 buy was The RMR Group: 117,245 shares worth $3.16M.
  • Invenomic Capital Management added most to UGI in Q1 2020, an estimated $1.26M increase.
  • Invenomic Capital Management's biggest Q1 2020 reduction was Bausch Health, cutting an estimated $4.16M.
  • Invenomic Capital Management fully exited JetBlue in Q1 2020, selling an estimated $6.96M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $122M portfolio in Q1 2020.
  • Invenomic Capital Management opened 64 new positions and closed 36 in Q1 2020.
  • Invenomic Capital Management's portfolio value fell 51% quarter-over-quarter to $122M.

Based on Invenomic Capital Management's 13F filing for Q1 2020, filed 13 May 2020.